The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Lustral 50 mg film-coated tablets

Upjohn EESVPA23055/001/001

Main Information

Trade NameLustral 50 mg film-coated tablets
Active SubstancesSertraline
Dosage FormFilm-coated tablet
Licence HolderUpjohn EESV
Licence NumberPA23055/001/001

Group Information

ATC CodeN06AB Selective serotonin reuptake inhibitors
N06AB06 sertraline


License statusAuthorised
Licence Issued19/08/1991
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0064-023-003
Interchangeable List DocumentPDF of Interchangeable List
« Back